Division of Cardiovascular Surgery, Peter Munk Cardiac Centre, Toronto General Hospital and University of Toronto, Toronto, Ontario, Canada.
J Thorac Cardiovasc Surg. 2011 Jul;142(1):155-61. doi: 10.1016/j.jtcvs.2010.12.005. Epub 2011 Feb 1.
Our objective was to examine whether preoperative non-dialysis-dependent renal dysfunction is associated with operative mortality or morbidity in isolated valve surgery.
We reviewed consecutive patients undergoing isolated aortic (n = 2132) or mitral valve (n = 1664) surgery, between 1996 and 2009. Preoperative renal dysfunction was defined as preoperative estimated glomerular filtration rate < 60 mL/min without dialysis. Propensity score 1:1 matched samples were created, one for aortic (n = 626) and one for mitral (n = 526) valve surgery.
The mean age was 70 ± 9 and 65 ± 10 years for the aortic and mitral groups, respectively. In the aortic cohort, patients with preoperative renal dysfunction had greater need for inotropes (39% vs 29%; P = .009), length of intensive care unit stay (27 vs 25 hours; P = .006), and duration of mechanical ventilation (8.2 vs 6.6 hours; P < .001). Operative mortality was 3.2% in the group with preoperative renal dysfunction and 2.2% in the group without preoperative renal dysfunction (P = .5). In the mitral cohort, patients with preoperative renal dysfunction had greater need for inotropes (47% vs 36%; P = .013), length of intensive care unit stay (40 vs 26 hours; P = .01), and duration of mechanical ventilation (7.2 vs 6.5 hours; P = .004). Operative mortality was 0% and 2.7% in the groups without and with preoperative renal dysfunction, respectively (P = .015).
Preoperative renal dysfunction is associated with higher morbidity in both cohorts, and patients undergoing mitral valve surgery also experienced higher mortality. The impact of non-dialysis-dependent preoperative renal dysfunction appears to be more pronounced in patients undergoing mitral valve surgery, potentially owing to their relative intolerance to volume overload.
本研究旨在探讨术前非透析依赖型肾功能不全与单纯瓣膜手术的手术死亡率或发病率之间的关系。
我们回顾了 1996 年至 2009 年间连续接受单纯主动脉瓣(n=2132)或二尖瓣(n=1664)手术的患者。术前肾功能不全定义为术前估算肾小球滤过率(eGFR)<60mL/min 且未透析。采用倾向评分 1:1 匹配方法,为主动脉瓣(n=626)和二尖瓣(n=526)手术分别创建一组匹配样本。
主动脉瓣组患者的平均年龄为 70±9 岁,二尖瓣瓣组患者的平均年龄为 65±10 岁。在主动脉瓣组中,术前肾功能不全的患者需要更多的正性肌力药物(39% vs 29%;P=0.009)、入住重症监护病房的时间(27 小时 vs 25 小时;P=0.006)和机械通气时间(8.2 小时 vs 6.6 小时;P<0.001)更长。术前肾功能不全组的手术死亡率为 3.2%,无术前肾功能不全组的手术死亡率为 2.2%(P=0.5)。在二尖瓣瓣组中,术前肾功能不全的患者需要更多的正性肌力药物(47% vs 36%;P=0.013)、入住重症监护病房的时间(40 小时 vs 26 小时;P=0.01)和机械通气时间(7.2 小时 vs 6.5 小时;P=0.004)更长。无术前肾功能不全组和有术前肾功能不全组的手术死亡率分别为 0%和 2.7%(P=0.015)。
术前肾功能不全与两组患者的发病率均较高相关,而接受二尖瓣手术的患者死亡率也较高。非透析依赖型术前肾功能不全的影响在接受二尖瓣手术的患者中似乎更为明显,这可能是由于他们对容量超负荷的相对不耐受。